Ad
Friday, 5 January 2018
Hungary's Richter expects Esmya drug ruling in first half: CEO
BUDAPEST (Reuters) - Hungarian drugmaker Richter expects European health inspectors to deliver a ruling on its Esmya medicine in the first half of 2018, its chief executive told Reuters, adding that uncertainty about the drug could delay earnings guidance.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment